| Característica |
Objectiu de la convocatòria
This grant program supports innovative projects across the full spectrum of basic, translational, clinical, epidemiological, health services, disparities, and social determinants of health research.
|
Característiques principals
Project topics include, but are not limited to:
Lung cancer biology
Identification of new biomarkers
Machine learning and digital pathology
Development of more effective and less toxic therapies including but not limited to targeted and immune-therapies
Genetic and gene-environment interactions
Interactions and contributions of multiple factors (e.g. smoking, genetics, environment, societal factors) to disparities in lung cancer outcomes
Mechanism of Antibody Drug Conjugates
Novel approaches to immunotherapy such as bispecific antibodies, vaccines, and cellular therapies
Bioengineering approaches to understanding and/or treating lung cancer (i.e., theranostics, biomaterials, nanotechnology, controlled-drug release, and gene therapy)
Supportive measures for people with lung cancer and their families, such as palliative care and telemedicine
Identification of metabolic vulnerabilities in lung cancer
|
Lloc de presentació
HMRIB and PSMAR staff who need more information should contact:
Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: [email protected] Ext.: 1670
Marta López: [email protected] Ext.: 1576
Júlia Vidal: [email protected] Ext.: 1736
|
Convocatòria (URL)
https://www.lungcancerresearchfoundation.org/research/funding-opportunities-2026/
|
Informació addicional
All applications for funding must be submitted online at Proposal Central through a two-stage process consisting of a letter of intent (LOI) and full proposal.
|
Requisits
Investigators must be primarily affiliated with a non-profit academic or research institution and must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators with less than seven years' experience since their initial faculty appointment. Exceptions may be granted for investigators with more years of experience in other disease areas or research topics.
Applicants from US-based and international institutions are eligible to apply and may hold any residency/citizenship status.
Applicants who have received or are receiving LCRF funding in the last four years are not eligible to apply.
Applicants may submit only one LCRF grant application per award cycle either as lead investigator or co-investigator.
Senior investigators with more than seven years' experience since faculty appointment are generally not eligible for funding and are encouraged to mentor a junior team member through the application process.
|
Dotació
USD 75,000 per year
|
Durada
Two years
|